-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Corcept Therapeutics Inc quarterly/annual Amortization of Intangible Assets history and growth rate from 2021 to 2023.
- Corcept Therapeutics Inc Amortization of Intangible Assets for the quarter ending March 31, 2024 was $52K, a 56.3% decline year-over-year.
- Corcept Therapeutics Inc annual Amortization of Intangible Assets for 2023 was $465K, a 2.52% decline from 2022.
- Corcept Therapeutics Inc annual Amortization of Intangible Assets for 2022 was $477K, a 16.6% increase from 2021.
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)